AbbVie makes $63B bid for Botox maker Allergan
Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth.
Jun 25, 2019
0
0